Skip to main content
Premium Trial:

Request an Annual Quote

Integrated Genomics Extends Software License to Biofuel Firm TMO

NEW YORK (GenomeWeb News) – Integrated Genomics has extended a license agreement with TMO Renewables for IG’s ERGO software for use in a cellulosic ethanol development program. 
Under the agreement, TMO will use IG’s software to identify pathways that can be used to upgrade TMO’s cellulosic ethanol program. Initially, the company plans to focus on its membrane transport proteins in its thermophilic strain.
The software is used to integrate biological data from genomics research, gene expression studies, genetics, and from sources in literature.
TMO’s ethanol production uses “high-temperature process organisms capable of producing bioethanol quickly and efficiently from a wide diversity of sustainable cellulosic feedstocks,” said Kirstin Eley, external program manager at TMO.
The ERGO software contains over 1,350 genomes that are in various stages of completion and more than 6,000 networked metabolic and non-metabolic pathways.
Financial terms of the agreement were not released.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.